AZ HB2757

Prohibits manufacturers and wholesale distributors from engaging in price gouging for essential off-patent or generic drugs, defined as prescription drugs with expired exclusive marketing rights that appear on the WHO essential medicines list or are designated as essential by the U.S. Department of Health and Human Services.

An "unconscionable increase" is defined as a price increase that is excessive, not justified by production costs or expanded access, and leaves consumers with no meaningful choice due to the drug's importance to their health and insufficient market competition.

Requires manufacturers to submit a statement within 45 days explaining cost components, manufacturing increases, and expenditures to expand drug access when the Attorney General requests information about price increases of at least 50% in a one-year period where a 30-day supply costs more than $80.

Authorizes the Arizona Attorney General to seek court orders that can restrain violations, restore consumer money, require manufacturers to offer drugs at pre-violation prices for up to one year, and impose civil penalties up to $10,000 per violation.

Requires the Attorney General to provide manufacturers an opportunity to justify price increases before bringing enforcement action and protects manufacturer and distributor information as confidential commercial information.